Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer

BACKGROUND: Pancreatic ductal carcinoma (PDC) is one of the most lethal human carcinomas. Expression patterns of some genes may predict gemcitabine (GEM) treatment efficacy. We examined predictive indicators of survival in GEM-treated patients by quantifying the expression of several genes in pre-tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Eto, K, Kawakami, H, Kuwatani, M, Kudo, T, Abe, Y, Kawahata, S, Takasawa, A, Fukuoka, M, Matsuno, Y, Asaka, M, Sakamoto, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629422/
https://www.ncbi.nlm.nih.gov/pubmed/23492684
http://dx.doi.org/10.1038/bjc.2013.108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629422/
https://www.ncbi.nlm.nih.gov/pubmed/23492684
http://dx.doi.org/10.1038/bjc.2013.108

Ejemplares similares